{"id":"W4309317888","doi":"10.25251/skin.6.supp.45","title":"Deucravacitinib, an oral, selective tyrosine kinase 2 inhibitor, versus placebo and apremilast in moderate to severe plaque psoriasis: analysis of body surface area involvement in the phase 3 POETYK PSO-1 and PSO-2 trials","year":2022,"lang":"en","type":"article","venue":"SKIN The Journal of Cutaneous Medicine","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"Université Laval; Centre de Recherche Dermatologique du Québec Métropolitain; Hôtel-Dieu de Québec","funders":"XBiotech; Bristol-Myers Squibb","keywords":"Apremilast; Plaque psoriasis; Placebo; Medicine; Psoriasis; Tyrosine-kinase inhibitor; Body surface area; Internal medicine; Pharmacology; Dermatology; Pathology; Psoriatic arthritis; Alternative medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002540235,0.0007557854,0.002870008,0.0003727709,0.000216362,0.001033951,0.0004910802,0.0007786115,0.002430968],"category_scores_gemma":[0.001704645,0.0003289607,0.002219883,0.0004007377,0.0005604214,0.000942102,0.0002392022,0.001764675,0.000348692],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006855439,"about_ca_system_score_gemma":0.0005844727,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000596735,"about_ca_topic_score_gemma":0.002189116,"domain_scores_codex":[0.9990613,0.0005708627,0.00006524505,0.000120817,0.00009307195,0.00008879377],"domain_scores_gemma":[0.9990292,0.0004037125,0.000215323,0.00005806365,0.00004927793,0.0002444305],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.9037998,0.002034601,0.003422227,0.001162543,0.004311491,0.00005076582,0.00005061716,0.001109346,0.00655151,0.000170092,0.001662472,0.07567453],"study_design_scores_gemma":[0.7369306,0.1975454,0.04530925,0.0001998466,0.008376651,0.0004981261,0.0001220539,0.002589761,0.002395602,0.0006977899,0.005253339,0.00008152239],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9651318,0.02901835,0.0004672311,0.0007139418,0.0002798054,0.000481624,0.001160953,0.0000993323,0.002646936],"genre_scores_gemma":[0.9905761,0.006197838,0.0003903162,0.0003946585,0.0001971811,0.000223708,0.0008782283,0.00001599091,0.001125773],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002870008,"threshold_uncertainty_score":0.01343417,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03984404570829199,"score_gpt":0.3064452367381327,"score_spread":0.2666011910298407,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}